Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
2.70
Nov 13 • 3:59 PM ET Dollar change-0.05 Percentage change(-1.82%)
Aftermarket Close
2.70
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 11, 8:32 PMTD Cowen slashes PIII target to $4 from $13 as shares drop 23% Wednesday
Index
-
Market Cap
19.60M
Enterprise Value
384.34M
Income
-75.97M
Sales
1.55B
Book/sh
-19.41
Cash/sh
6.31
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
320
IPO
Apr 06, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
0.01
P/B
-
P/C
0.43
P/FCF
-
EV/EBITDA
140.78
EV/Sales
0.25
Quick Ratio
0.53
Current Ratio
0.53
Debt/Eq
1.23
LT Debt/Eq
0.44
Option/Short
No / Yes
EPS (ttm)
-23.26
EPS next Y
-11.72
EPS next Q
-4.79
EPS this Y
90.10%
EPS next Y
-161.61%
EPS next 5Y
45.87%
EPS past 3/5Y
48.16% -2.64%
Sales past 3/5Y
11.61% 24.33%
EPS Y/Y TTM
42.43%
Sales Y/Y TTM
7.54%
EPS Q/Q
100.70%
Sales Q/Q
14.80%
Insider Own
50.94%
Insider Trans
-1.33%
Inst Own
7.53%
Inst Trans
-4.96%
ROA
-7.57%
ROE
-115.66%
ROIC
-33.14%
Gross Margin
3.95%
Oper. Margin
-5.24%
Profit Margin
-4.89%
SMA20
-28.75%
SMA50
-51.20%
SMA200
-59.03%
Trades
Shs Outstand
4.02M
Shs Float
1.97M
52W High
16.89 -84.01%
52W Low
1.52 77.63%
Volatility
23.22% 12.94%
ATR (14)
0.51
RSI (14)
28.48
Beta
1.82
Rel Volume
0.95
Avg Volume
31.01K
Volume
29,471
Perf Week
-32.50%
Perf Month
-34.78%
Perf Quarter
-74.46%
Perf Half Y
-76.09%
Perf YTD
-22.64%
Perf Year
-61.43%
Perf 3Y
-95.83%
Perf 5Y
-99.46%
Perf 10Y
-
Prev Close
2.75
Price
2.70
Change %
-1.82%
Consensus
Buy
Avg. Price Target
$7.75
Implied Upside
+187.0%
Analysts3incl. previous ratings
Rating Distribution1 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 28, 2025Resumed
LLake Street
Buy$20+640.7%
Apr 01, 2024Downgrade
BBTIG Research
Buy → Neutral
Sep 01, 2023Initiated
BBTIG Research
Buy$5+85.2%
Jun 30, 2023Initiated
TD logoTTD Cowen
Market Perform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hudson Vegas Investment SPV, L10% OwnerAug 10 '26Sale16.4850,000823,9270Aug 12 04:30 PM
P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The firm offers capital care model, data and technology, physician leadership, and community outreach tools to create patient outcomes and experiences. The company was founded by Sherif Abdou and Amir Bacchus on August 20, 2020 and is headquartered in Henderson, NV.
CEODr. Aric Coffman M.D.
M.D.Dr. Amir Bacchus M.B.A.
Chief Financial OfficerMr. Leif Pedersen
Executive VP & COOMr. William Bettermann
Senior Vice President of TechnologyMr. Devery Goodey